Can menopausal hormone therapy affect heart function after menopause?
Official title: Menopausal Hormone Therapy And Neural Control Of Left Ventricular Function
Run by Mayo Clinic · NCT07242391 · Data updated 2026-11-12
This study tests whether menopausal hormone therapy changes how the heart responds to stress in women who are past menopause.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 45 Years to 60 Years |
| Sex | Women only |
| Enrollment | 50 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Rochester, Minnesota) |
| Status | Recruiting |
| Started | August 26, 2026 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | August 27, 2026 |
| Trial ID | NCT07242391 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women over 45 who are postmenopausal and either using menopausal hormone therapy or not, with no significant heart disease or CNS-active medications as specified.
✕Probably not a fit
Women with certain preexisting heart conditions or taking excluded medications may not experience any cardiovascular benefit from the study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study compares left ventricular stroke volume and heart rate responses to bursts of sympathetic nerve activity in menopausal women who use menopausal hormone therapy versus those who do not. Participants are women over 45 years who are postmenopausal and meet specific health criteria. Data are collected at Mayo Clinic in Rochester to explore whether hormone therapy influences cardiac responses in this population. The study does not involve new treatments beyond the existing use of menopausal hormone therapy. Results may help clarify potential cardiovascular effects of hormone therapy after menopause.
Why it matters
Potential benefit: If successful, findings could inform safer use of menopausal hormone therapy with respect to heart function after menopause.
How similar studies have gone: Prior research has explored hormone therapy and cardiovascular effects, but this observational approach addressing sympathetic nerve activity responses is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria • \>45-60\< years of age Exclusion Criteria * Male sex * Females between STRAW+10 stages -5 and 0 * PMF in STRAW+10 stage +2 * PMF using oral hormone therapy * Females who entered menopause due to a surgical procedure or in response to pharmacotherapy (e.g., gonadotrophin releasing hormone agonists or chemotherapy) * Heart disease such as hypertropic cardiomyopathy, congenital abnormalities, chronic heart failure, valve disease, and a history of myocardial infarction * Medications that impact the central nervous system including selective serotonin reuptake inhibitors, anxiolytics, sedatives, anticholinergic agents, dopamine, amphetamines, or wake-promoting agents (e.g., modafinil). Other medications will be evaluated on an individual basis by the PI. * Cardiovascular medications is also an exclusion criterion which includes those acting on the renin-angiotensin-aldosterone axis, adrenergic receptor antagonists, diuretics, nitrates, and calcium channel antagonists. Other medications will be evaluated on an individual basis by the PI. * Pregnancy * COPD * Diabetes * CKD * Raynaud's phenomenon * Sleep disorders * Shift workers * BMI ≥40.0kg/m2 * Use of nicotine-containing products within the two years preceding study visits * Active cancer treatment
Where it's running
-
Mayo Clinic in Rochester
Rochester, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Joshua Bock, Ph.D. — Mayo Clinic
- Study coordinator: Joshua Bock, Ph.D.
- Email: bock.joshua@mayo.edu
- Phone: 507-422-0768
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hop extract vs soy isoflavone for menopausal symptoms
This study tests whether a full-spectrum hop extract helps reduce menopausal mood symptoms better than soy isoflavones in peri- and postmenopausal women.
-
Resveratrol and Estrogen Receptors in Postmenopausal Women with CAD
This study tests whether taking resveratrol is safe and can change estrogen-related markers in postmenopausal women with coronary artery disease.
-
Ashoka Bark and Shatavari for Menopause
This 12-week study tests whether a daily Ashoka Bark and Shatavari supplement helps reduce menopausal symptoms in postmenopausal women compared with a placebo.
-
Lifestyle changes to ease menopausal symptoms, sleep problems, and anxiety
Researchers are testing whether a structured lifestyle education program helps perimenopausal and postmenopausal women see fewer menopausal symptoms, better sleep, and less anxiety compared to usual care.
-
Pain and period life: does menstrual cycle or menopause change pain during root canals?
This study will see if pain during a root canal varies with menstrual cycle phase or menopausal status in adult patients.
-
Sex hormones, menopause, and exercise in aging women
This study tests how hormonal status and resistance training affect age-related muscle and nerve function in postmenopausal women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.